Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in Adults With NAFLD
NCT04031729Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2019
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in non-alcoholic fatty liver disease (NAFLD), sponsored by Massachusetts General Hospital. Started Sep 2019; status: completed.
02
Drugs
aspirin
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT04031729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04031729.